During the period from 2023 to 2031, the market for single-use bioprocessing is anticipated to grow at a CAGR of 18%, driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing processes. The benefits of single-use bioprocessing systems include adaptability, cost-effectiveness, decreased risk of cross-contamination, and simplified cleansing and validation procedures. These factors have contributed to the revenue growth ...
Read More »